drugset / Trial / NCT03154125

Sayana® Press Extension Study

NCT03154125

Phase 3 Completed 750 enrolled FHI 360
RandomizedParallel-groupSingle-blindOther

Summary

This is a randomized clinical trial designed to evaluate the effectiveness, safety and acceptability of Sayana® Press when injected every 4 months (17-18 weeks) for 3 treatment cycles (12 months) of use.

Timeline

Start
2017-09-22
Primary completion
2020-05-30
Completion
2020-11-18

Drugs

EvaluationDrugModalityDoseRoute
Subject medroxyprogesterone acetate Other / unclassified 104 mg Subcutaneous

Indications

No indication recorded.